United States News Todas as matérias

Merlin (NASDAQ:MRLN) reported its inaugural quarterly results as a public company on Thursday, unveiling a new product family designed to bring autonomous flight to large, multi-crew aircraft.

Intuitive Machines (NASDAQ:LUNR) reported record-breaking first-quarter results on Thursday, signaling its transition from a specialized lunar landing firm into a scaled aerospace prime contractor.

WhiteFiber (NASDAQ:WYFI) reported strong top-line growth for the first quarter of 2026, driven by a surge in demand for AI-focused high-performance computing (HPC) and colocation services.

Grocery Outlet (NASDAQ:GO) reported a first-quarter net loss of $180.3 million, or $1.83 per diluted share, compared with a net loss of $23.3 million in the same period last year.

Cisco (NASDAQ:CSCO) reported third-quarter fiscal 2026 revenue of $15.8 billion, a 12% increase from the prior-year period.

Jack in the Box (NASDAQ:JACK) reported total revenue of $254.3 million for the second quarter ended April 12, 2026, a 4.3% decrease from $265.7 million in the prior-year period.

BeOne Medicines (NASDAQ:ONC) announced that Beqalzi is now authorized for MCL patients who have previously been treated with a Bruton’s tyrosine kinase (BTK) inhibitor.

Immunic (NASDAQ:IMUX) announced Wednesday that it ended the first quarter with $186.6 million in cash and cash equivalents, a significant increase from year-end 2025.

Gilat Satellite Networks (NASDAQ:GILT) reported a powerful start to 2026, delivering a "beat-and-raise" style performance in its first-quarter results.

Tower Semiconductor (NASDAQ:TSEM) reported a robust start to fiscal year 2026, delivering a double-digit revenue increase and nearly doubling its operating profit as demand for AI data center infrastructure accelerates.

AIRO Group Holdings (NASDAQ:AIRO) reported a decline in first-quarter revenue and a widening net loss Thursday, as the aerospace and defense newcomer works through a transition in product mix and timing of shipments.

STAAR Surgical (NASDAQ:STAA) reported first-quarter net sales of $93.5 million, an 119.6% increase over the $42.6 million recorded in the first quarter of 2025.

Veru (NASDAQ:VERU) reported a net loss of $2.7 million, or $0.12 per share, for the three months ended March 31, 2026.

Johnson Controls (NYSE:JCI) announced the successful closure of its acquisition of Alloy Enterprises, finalized nearly three months after the agreement was first unveiled on Feb. 18, 2026.

Neonode (NASDAQ:NEON) reported first-quarter revenue from continuing operations of $0.6 million, a 19.7% increase compared to the same period in 2025.

FedEx (NYSE:FDX) announced that it will execute the separation of its freight business through a tax-free, pro rata dividend of 80.1% of the outstanding shares of the newly formed FedEx Freight Holding Company.

Compass Pathways (NASDAQ:CMPS) reported first-quarter net income of $91.2 million, or $0.71 per basic share, a dramatic reversal from the $17.9 million loss recorded in the same period last year.

DarioHealth (NASDAQ:DRIO) posted first-quarter revenue of $5.6 million, a 6.7% increase from the fourth quarter of 2025.

Nebius Group (NASDAQ:NBIS) reported a first-quarter profit of $621.2 million, or $2.11 per share.

CTW (NASDAQ:CTW) announced Wednesday that revenue for the six months ending January 31, 2026, reached $40.9 million, a 1% decline from the $41.2 million reported in the prior-year period.

Costamare Bulkers (NYSE:CMDB) reported first-quarter net income of $9.9 million, or $0.41 per share.

Valens Semiconductor (NYSE:VLN) posted first-quarter revenue of $16.9 million, edging past its guidance range of $16.3 million to $16.7 million.

Pfizer (NYSE:PFE) announced Wednesday that European regulators have cleared Hympavzi for adolescents and adults with hemophilia A or B with inhibitors, marking a significant expansion for the non-factor therapy in the 27 EU member states, Iceland, Liechtenstein, and Norway.

Arbutus Biopharma (NASDAQ:ABUS), a clinical-stage biopharmaceutical company focused on infectious diseases, reported its financial results for the first quarter ended March 31, 2026.